<SEC-DOCUMENT>0001193125-24-076468.txt : 20240325
<SEC-HEADER>0001193125-24-076468.hdr.sgml : 20240325
<ACCEPTANCE-DATETIME>20240325160350
ACCESSION NUMBER:		0001193125-24-076468
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240325
DATE AS OF CHANGE:		20240325

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SYNOPSYS INC
		CENTRAL INDEX KEY:			0000883241
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				561546236
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19807
		FILM NUMBER:		24779180

	BUSINESS ADDRESS:	
		STREET 1:		675 ALMANOR AVE
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94085
		BUSINESS PHONE:		6505845000

	MAIL ADDRESS:	
		STREET 1:		675 ALMANOR AVE
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94085
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d814976ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No. ) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&#8194;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&#8194;&#9744; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT> </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g814976g0325075550338.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Synopsys, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check all boxes that apply): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Additional Information Concerning the 2024 Annual Meeting of Stockholders of
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Synopsys, Inc. to be Held on April&nbsp;10, 2024 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As set forth in our Definitive Proxy Statement filed with the Securities and Exchange Commission and first mailed or made available to our stockholders on
February&nbsp;16, 2024, our Corporate Governance Guidelines provide that whenever the Chair of our Board of Directors (the &#147;Board&#148;) also serves as our Chief Executive Officer (&#147;CEO&#148;), or is otherwise not an independent director
in accordance with the applicable federal securities laws and the Nasdaq Listing Standards, we will appoint an independent director to serve as Lead Independent Director to provide independent oversight of management and provide leadership for the
independent directors of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;25, 2024, our Board amended our Bylaws and Corporate Governance Guidelines, effective immediately, to
provide for the appointment of our Lead Independent Director by the independent directors of the Board, rather than the full Board. Our amended Corporate Governance Guidelines, which we have made available on our website, were also amended to
clarify that the Lead Independent Director has explicit approval authority when it comes to approving the agenda, schedule, and materials for meetings of the full Board, and that the Lead Independent Director shall serve as the primary point of
contact for stockholders who wish to engage directly with the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that these amendments to our Corporate Governance Guidelines further
underscore the robust role of our Lead Independent Director in providing appropriate leadership to the independent directors of the Board and oversight of management, without negatively impacting the advantages of our current Board leadership
structure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A summary of the duties of our Executive Chair, Lead Independent Director, and President, Chief Executive Officer and Director is
provided&nbsp;below. While our Executive Chair and President and CEO have entered into employment agreements with Synopsys, their employment is <FONT STYLE="white-space:nowrap">at-will</FONT> and can be terminated by us at any time, and their
continual membership on our Board is subject to their being reelected by our stockholders. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>Executive Chair</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Lead Independent Director</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>President and CEO</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:1.00em; font-size:10pt; font-family:Times New Roman"><B>Dr.&nbsp;Aart de Geus</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:1.00em; font-size:10pt; font-family:Times New Roman"><B>Roy Vallee</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:1.00em; font-size:10pt; font-family:Times New Roman"><B>Sassine Ghazi</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Review and advise on agenda and materials for regular Board meetings with the
Lead Independent Director and&nbsp;CEO.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Review and advise on schedule of regular Board meetings.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Serve as chair of regular
Board&nbsp;meetings.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Guide discussions at Board and Committee meetings.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Communicate with directors on
key issues outside of Board meetings.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Advise and support the CEO and management on Synopsys&#146; long-term strategy.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Approve agenda and materials for regular Board meetings with the Executive Chair
and CEO.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Approve schedule
of regular Board meetings with the Executive Chair and CEO.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Serve as chair of regular Board meetings when the Executive Chair is&nbsp;unavailable.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Call executive sessions of
the independent directors, establish the agenda for, and preside at such&nbsp;sessions.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Provide feedback from executive sessions to management.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Establish the strategic direction and drive&nbsp;value creation
of&nbsp;Synopsys.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Represent the face of Synopsys to various stakeholders.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Set meaningful and measurable
operating&nbsp;and strategic goals for&nbsp;the&nbsp;company.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Drive operational execution.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Build and guide a highly
capable and dynamic leadership&nbsp;team.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Establish a strong performance management culture.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Serve as primary interface
between management and the&nbsp;Board.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Maintain key strategic relationships and stakeholder communications,
as&nbsp;appropriate.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Champion Synopsys&#146; culture and technological innovation both within and outside the
company.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Serve as liaison between the CEO, Executive Chair and the independent
directors.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Preside over
periodic meetings of the independent directors.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Participate in the annual performance evaluation of the&nbsp;CEO.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Facilitate dialogue between
the independent directors and&nbsp;management.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Serve as the primary point of contact for stockholders who wish to engage directly with the
Board.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Provide regular updates and information to the Board on key issues, including
business developments and status of&nbsp;operations.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Review organizational structure needs and develop ongoing management succession plans.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Assist the Compensation
Committee in assessing the performance of the leadership team and provide guidance and mentorship to individual leaders.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Anticipate and mitigate potential risks to Synopsys, and help ensure such risks are identified,
minimized and reported to the Board or committees, as appropriate.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g814976g0325075550338.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g814976g0325075550338.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  T .<# 2(  A$! Q$!_\0
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M?$%[]J R-Y^4FN(T+QWX@\-^($M;Z\>[MEF$,L+]%R<9%?0S_<;Z&OE77/\
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M=KI#6\0Q''"54>P%?,VB?\CU8?\ 81_K7T]>?\>4_P#US;^5?,.B?\CU8?\
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GKIVB736Z$,\YW%CDFN]HHHK_ ,1BG\3"BBBL20HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
